Basetti Madhu

Basetti Madhu

UNVERIFIED PROFILE

Are you Basetti Madhu?   Register this Author

Register author
Basetti Madhu

Basetti Madhu

Publications by authors named "Basetti Madhu"

Are you Basetti Madhu?   Register this Author

26Publications

487Reads

49Profile Views

The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia.

Cell Metab 2018 04;27(4):898-913.e7

Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK; Department of Cell and Molecular Biology, Karolinska Institute, Stockholm SE-171 77, Sweden. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15504131183013
Publisher Site
http://dx.doi.org/10.1016/j.cmet.2018.02.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887987PMC
April 2018

Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS 1H NMR spectra.

PLoS One 2017 25;12(10):e0185980. Epub 2017 Oct 25.

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185980PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656327PMC
November 2017

Special Issue: Cancer Metabolism.

Authors:
Madhu Basetti

Metabolites 2017 Aug 9;7(3). Epub 2017 Aug 9.

Imaging Core, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/metabo7030041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618326PMC
August 2017

Response of Degarelix treatment in human prostate cancer monitored by HR-MAS H NMR spectroscopy.

Metabolomics 2016;12:120. Epub 2016 Jun 30.

Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge, CB2 0RE UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11306-016-1055-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927592PMC
June 2016

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.

J Natl Cancer Inst 2016 May 11;108(5). Epub 2015 Dec 11.

Affiliations of authors:Cancer Research UK Cambridge Institute, University of Cambridge , Cambridge, UK (MA, CEM, NP, HIZ, AQ, AB, SM, BM, CE, SL, SW, VRZ, GS, RR, HM, AGL, CD, CT, AL, RS, JY, RS, JSC, JRG, ST, DEN); School of Medical Sciences, University of Aberdeen , Aberdeen, UK (FO, IJM); Department of Pathology, Addenbrooke's Hospital , Cambridge, UK (AYW, NS); Institute of Human Genetics, Jena University Hospital , Jena , Germany (ME, KL, WH, AB); Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, Faculty of Health Sciences, University of Adelaide , Australia (LAS, WDT); Freemasons Foundation Centre for Men's Health, School of Medicine, Faculty of Health Sciences, University of Adelaide , Australia (LAS, WDT); Diatherix , Huntsville, AL (EG); Masonic Cancer Center, University of Minnesota , Minneapolis, MN (SMD); The Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia , Vancouver BC , Canada (PSR); Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital , Oslo , Norway (IGM); Department of Cancer Prevention, Institute of Cancer Research and Department of Urology, Oslo University Hospital , Oslo , Norway (IGM); Prostate Cancer UK/Movember Centre of Excellence, Queens University , Belfast , UK (IGM); Department of Oncology, Addenbrooke's Hospital , Cambridge, UK (MA, DEN).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/5/djv371.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv37
Publisher Site
http://dx.doi.org/10.1093/jnci/djv371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849803PMC
May 2016

Artefacts in 1H NMR-based metabolomic studies on cell cultures.

MAGMA 2015 Apr 10;28(2):161-71. Epub 2014 Aug 10.

Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Robinson Way, Cambridge, CB2 0RE, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10334-014-0458-zDOI Listing
April 2015

Normalization of metabolomics data with applications to correlation maps.

Bioinformatics 2014 Aug 7;30(15):2155-61. Epub 2014 Apr 7.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, SE-171 77 Stockholm, Sweden and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btu175DOI Listing
August 2014

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer.

EMBO J 2014 Jun 16;33(12):1365-82. Epub 2014 May 16.

Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership University of Oslo and Oslo University Hospital, Oslo, Norway Department of Cancer Prevention and Urology, Institute of Cancer Research and Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/embj.201386874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194125PMC
June 2014

Magnetic resonance spectroscopy of cancer metabolism and response to therapy.

Radiat Res 2012 Apr 8;177(4):398-435. Epub 2012 Mar 8.

Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1667/rr2903.1DOI Listing
April 2012

Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS.

J Magn Reson Imaging 2008 Nov;28(5):1201-8

Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.21577DOI Listing
November 2008

Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice.

Circ Res 2008 May 3;102(9):1046-56. Epub 2008 Apr 3.

Cardiovascular Division, The James Black Centre, King's College, University of London, 125 Coldharbour Ln, London SE5 9NU, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.108.174623DOI Listing
May 2008

Proteomics and metabolomics combined in cardiovascular research.

Trends Cardiovasc Med 2007 Feb;17(2):43-8

Cardiovascular Division, King's College, London SE5 9NU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2006.11.004DOI Listing
February 2007

The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.

Neoplasia 2006 Jul;8(7):560-7

Cancer Research UK Biomedical Magnetic Resonance Research Group, Division of Basic Medical Sciences, St. George's, University of London, London SW17 ORE, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147655860680011
Publisher Site
http://dx.doi.org/10.1593/neo.06319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1601935PMC
July 2006

Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.

Cancer Res 2006 Jan;66(1):427-34

Cancer Research UK Clinical Magnetic Resonance Research Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1338DOI Listing
January 2006

Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.

Clin Cancer Res 2005 May;11(10):3705-13

Department of Basic Medical Sciences, St. George's Hospital Medical School and Antisoma Research, Ltd., London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2504DOI Listing
May 2005